NCT02315521 Standardized Prenatal Clinical Care for LUTO
| NCT ID | NCT02315521 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baylor College of Medicine |
| Condition | Urethral Obstruction |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2014-12 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2014-12 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators propose a standardized prenatal management, based on the scientific evidence published in the literature, to manage prenatally fetuses with lower urinary tract obstruction (LUTO). The present study is a prospective registry that will evaluate and validate this standardized prenatal management for LUTO.
Eligibility Criteria
Inclusion Criteria: \- Pregnant women whose fetuses have diagnosis of LUTO independently from the gestational age at diagnosis. Exclusion Criteria: * Presence of abnormal chromosomal/genetic disease * Presence of other associated structural anomaly that is not part of LUTO.
Contact & Investigator
Michael Belfort, MD PHD
PRINCIPAL INVESTIGATOR
Baylor College of Medicine
Frequently Asked Questions
Who can join the NCT02315521 clinical trial?
This trial is open to participants of all sexes, aged 11 Weeks or older, up to 2 Years, studying Urethral Obstruction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02315521 currently recruiting?
Yes, NCT02315521 is actively recruiting participants. Contact the research team at belfort@bcm.edu for enrollment information.
Where is the NCT02315521 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT02315521 clinical trial?
NCT02315521 is sponsored by Baylor College of Medicine. The principal investigator is Michael Belfort, MD PHD at Baylor College of Medicine. The trial plans to enroll 50 participants.